查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1963958

血酮儀市場－全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、最終用途、地區和競爭對手分類，2021-2031年

Blood Ketone Meter Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球血液酮體分析儀市場預計將從 2025 年的 4.5518 億美元成長到 2031 年的 6.8733 億美元，複合年成長率為 7.11%。

這些診斷設備對於測量毛細血管血液中的酮體濃度至關重要，在代謝健康和糖尿病管理中發揮關鍵作用。市場成長的主要促進因素包括：全球糖尿病盛行率不斷上升、需要精準檢測以避免危及生命的糖尿病併發症（例如糖尿病酮酸症），以及生酮飲食在體重管理中的日益普及。根據國際糖尿病聯盟 (IDF) 預測，到 2024 年，全球將有約 5.89 億成年人患有糖尿病，如此龐大的患者群體從根本上支撐了對精準、即時代謝監測解決方案的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 4.5518億美元
市場規模：2031年 6.8733億美元
複合年成長率：2026-2031年 7.11%
成長最快的細分市場 血糖值和酮體監測
最大的市場 北美洲

儘管有這些有利條件，但一次性試紙的高昂成本仍然是市場成長的一大障礙。頻繁檢測帶來的持續經濟負擔限制了使用者的長期接受度，並阻礙了其在發展中地區的市場滲透。這種價格承受能力問題仍然是限制血液酮體監測技術在更廣泛經濟領域商業性化推廣的主要阻礙因素。

市場促進因素

全球糖尿病盛行率的不斷上升是血糖和酮體檢測儀市場的主要驅動力，凸顯了嚴格管理通訊協定對於預防糖尿病酮酸症等併發症的必要性。隨著糖尿病患者人數的增加，對能夠同時測量血糖值和酮體水平的精準雙功能設備的需求日益成長，尤其對於胰島素依賴型患者而言。糖尿病發生率的上升直接導致醫療系統和個人對診斷技術的採購量增加。例如，雅培公司在2024年10月發布的2024年第三季財報中指出，其全球糖尿病照護產品銷售額達到16億美元，反映出市場對先進代謝監測工具的極高需求。

同時，生酮飲食和低碳水化合物飲食在最佳化代謝健康方面的應用正在迅速成長，顯著拓展了市場範圍，使其超越了臨床病理學領域。這種以消費者為中心的轉變主要受全球肥胖危機的驅動，促使人們使用血酮監測儀來追蹤進展。根據世界衛生組織（WHO）2024年3月發布的「2024年世界肥胖日」新聞稿，目前全球有超過10億人患有肥胖症，這是一個亟需改善代謝的龐大群體。這種對持續健康監測的關注也體現在該行業的財務業績上，Dexcom公司報告稱，其2024年第三季度的收入成長至9.942億美元，凸顯了代謝監測領域持續的商業性發展勢頭。

市場挑戰

一次性試紙的高昂價格是全球血酮監測市場永續發展的主要障礙。與診斷設備本身所需的初始投資不同，購買試紙的成本是持續性的，這往往會成為長期管理的阻礙。這種定價結構造成了醫療資源取得的不平等，尤其是在對價格敏感、自付醫療費用高昂的發展中地區。因此，潛在用戶往往會放棄定期進行血酮監測或減少試紙的使用，直接減少了製造商賴以拓展市場的持續收入來源。

疾病管理相關的巨額總成本進一步加劇了這種經濟壓力，迫使患者和醫療系統優先投資於基本藥物而非監測技術。根據國際糖尿病聯盟（IDF）估計，到2024年，全球糖尿病醫療支出預計將達到1.015兆美元。如此巨大的財政負擔表明，醫療預算已捉襟見肘，使得支付方和個人難以承擔專用酮體檢測設備的額外成本。因此，這些設備在不同經濟階層的普及率仍然較低，阻礙了市場充分發揮其商業性潛力。

市場趨勢

穿戴式連續酮體監測技術的開發，透過提供自動化、即時的代謝監測，解決了間歇性檢測的許多限制。這項創新對於胰島素依賴型患者尤其重要，因為他們常常忽略手動篩檢，而忽略了糖尿病酮酸症的嚴重風險。業界正積極轉向使用這些生物感測器，以彌補傳統指尖採血方法的依從性不足，確保能夠即時檢測到危險的代謝變化。根據 Medscape 2025 年 4 月發布的報告《連續酮體監測：必要還是可有可無？ 》，一項針對 2995 名 1 型糖尿病患者的調查顯示，50% 的成年人表示，在感覺不適時根本不會測量酮體水平，這凸顯了自動化穿戴式感測器必須填補的重大安全漏洞。

同時，將酮體數據整合到遠端醫療和遠端監測平台中，正在創造一種新型的慢性病管理模式，該模式將生物標記數據直接納入虛擬醫療模型。這種協作使醫療專業人員能夠根據即時回饋動態調整營養和胰島素治療方案，與靜態治療通訊協定相比，顯著改善患者的治療效果。將酮體測量數據與雲端系統同步，使醫療服務提供者能夠監測患者對生酮療法的依從性，並在無需面對面諮詢的情況下預防併發症。根據 Virta Health 於 2025 年 11 月發布的《代謝疾病逆轉年度報告》，該公司的遠距醫療平台在其會員中實現了 60% 的 2 型糖尿病逆轉率，證明了互聯酮體感測生態系統的商業性和臨床可行性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球血酮儀市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品類型（血酮監測、血糖和酮體同步監測）
    • 透過應用（用於人類，用於獸醫）
    • 依最終用途（醫院、診斷中心、居家醫療環境、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美血酮儀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲血酮儀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區血酮儀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲血酮儀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲血酮儀市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球血酮儀市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories, Inc.
  • APEX Biotechnology Corporation
  • TaiDoc Technology Corporation
  • EKF Diagnostics Holdings plc
  • Nipro Corporation
  • ForaCare Inc.
  • Menarini Diagnostics Srl
  • ACON Laboratories Inc.
  • GlucoRx Limited
  • Illumina, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24376

The Global Blood Ketone Meter Market is projected to expand from USD 455.18 Million in 2025 to USD 687.33 Million by 2031, progressing at a CAGR of 7.11%. These diagnostic devices are essential for measuring ketone body concentrations in capillary blood, playing a pivotal role in managing metabolic health and diabetes. The market's growth is primarily fueled by the rising global incidence of diabetes, which demands precise testing to avert life-threatening complications like diabetic ketoacidosis, as well as the increasing adoption of ketogenic diets for weight control. As reported by the International Diabetes Federation, approximately 589 million adults were living with diabetes worldwide in 2024, a vast patient base that fundamentally underpins the demand for accurate and immediate metabolic monitoring solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 455.18 Million
Market Size 2031USD 687.33 Million
CAGR 2026-20317.11%
Fastest Growing SegmentBlood Glucose & Ketone Monitoring
Largest MarketNorth America

Despite these positive drivers, the market confronts a major obstacle regarding the high recurring cost of disposable test strips. The ongoing financial strain linked to frequent testing often restricts access for long-term users and limits market penetration in developing regions. This affordability issue remains a primary constraint that could impede the widespread commercial expansion of blood ketone monitoring technologies across broader economic demographics.

Market Driver

The increasing global prevalence of diabetes mellitus serves as a primary force propelling the Blood Ketone Meter Market, highlighting the need for strict management protocols to prevent complications such as diabetic ketoacidosis. As the diabetic population grows, there is an intensified demand for precise, dual-function devices capable of monitoring both glucose and ketone levels, particularly for insulin-dependent patients. This rise in disease incidence leads directly to higher procurement of diagnostic technologies by healthcare systems and individuals; for instance, Abbott reported in their 'Third Quarter 2024 Financial Results' in October 2024 that global Diabetes Care sales hit $1.6 billion, reflecting the critical need for advanced metabolic monitoring tools.

Simultaneously, the surging adoption of ketogenic and low-carbohydrate diets for metabolic health optimization has significantly broadened the addressable market beyond clinical pathology. This consumer-centric shift is largely driven by the global obesity crisis, compelling individuals to utilize blood ketone meters for tracking nutritional ketosis and weight management progress. According to the World Health Organization's 'World Obesity Day 2024' news release in March 2024, over 1 billion people worldwide are now living with obesity, creating a massive demographic seeking metabolic interventions. This focus on continuous health monitoring is further evidenced by the sector's financial performance, with Dexcom reporting that third-quarter revenue grew to $994.2 million in 2024, underscoring the sustained commercial momentum within the metabolic monitoring landscape.

Market Challenge

The substantial recurring cost of disposable test strips constitutes a significant barrier to the sustainable growth of the global blood ketone meter market. Unlike the one-time investment required for the diagnostic device itself, the financial obligation associated with purchasing test strips is continuous and often prohibitive for long-term management. This pricing structure creates a disparity in access, particularly in price-sensitive developing regions where out-of-pocket healthcare expenses are high. Consequently, potential users often forgo regular ketone monitoring or ration their testing supplies, which directly reduces the recurring revenue streams that manufacturers rely upon for market expansion.

This economic pressure is further intensified by the overwhelming broader costs of managing the condition, which forces patients and healthcare systems to prioritize essential medications over monitoring technologies. According to the International Diabetes Federation, in 2024, diabetes was responsible for an estimated USD 1.015 trillion in global health expenditure. This massive financial burden indicates that healthcare budgets are already stretched to their limits, making it difficult for payers and individuals to absorb the additional expense of specialized ketone testing supplies. As a result, the adoption rate of these devices remains suppressed in economically diverse demographics, preventing the market from reaching its full commercial potential.

Market Trends

The development of Wearable Continuous Ketone Monitoring Technologies is addressing the critical limitations of episodic testing by offering automated, real-time metabolic surveillance. This innovation is particularly vital for insulin-dependent patients who frequently neglect manual screening despite the severe risks of diabetic ketoacidosis. The industry is aggressively pivoting toward these biosensors to close the adherence gap left by traditional finger-stick methods, ensuring that dangerous metabolic shifts are detected immediately. According to a Medscape report titled 'Continuous Ketone Monitoring: Essential or Optional?' from April 2025, a survey of 2,995 individuals with type 1 diabetes revealed that 50% of adults reported never checking for ketones during illness, highlighting a substantial safety void that automated wearable sensors are designed to fill.

Concurrently, the incorporation of ketone data into telehealth and remote monitoring platforms is redefining chronic disease management by integrating biomarker data directly into virtual care models. This connectivity allows clinicians to dynamically adjust nutritional or insulin therapies based on real-time feedback, significantly improving patient outcomes compared to static treatment protocols. By synchronizing ketone readings with cloud-based systems, providers can oversee compliance with ketogenic interventions or prevent complications without requiring in-person visits. According to Virta Health's 'Annual Report on Metabolic Disease Reversal' from November 2025, their remote care platform achieved a 60% type 2 diabetes reversal rate among members, demonstrating the commercial and clinical viability of connected ketone sensing ecosystems.

Key Market Players

  • Abbott Laboratories, Inc.
  • APEX Biotechnology Corporation
  • TaiDoc Technology Corporation
  • EKF Diagnostics Holdings plc
  • Nipro Corporation
  • ForaCare Inc.
  • Menarini Diagnostics Srl
  • ACON Laboratories Inc.
  • GlucoRx Limited
  • Illumina, Inc.

Report Scope

In this report, the Global Blood Ketone Meter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Ketone Meter Market, By Product Type

  • Blood Ketone Monitoring
  • Blood Glucose & Ketone Monitoring

Blood Ketone Meter Market, By Application

  • Human
  • Veterinary

Blood Ketone Meter Market, By End Use

  • Hospitals
  • Diagnostic Centers
  • Homecare Settings
  • Others

Blood Ketone Meter Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Ketone Meter Market.

Available Customizations:

Global Blood Ketone Meter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Ketone Meter Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Blood Ketone Monitoring, Blood Glucose & Ketone Monitoring)
    • 5.2.2. By Application (Human, Veterinary)
    • 5.2.3. By End Use (Hospitals, Diagnostic Centers, Homecare Settings, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Blood Ketone Meter Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blood Ketone Meter Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Blood Ketone Meter Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Blood Ketone Meter Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Blood Ketone Meter Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blood Ketone Meter Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Blood Ketone Meter Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Blood Ketone Meter Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Blood Ketone Meter Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Blood Ketone Meter Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia Pacific Blood Ketone Meter Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Blood Ketone Meter Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Blood Ketone Meter Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Blood Ketone Meter Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Blood Ketone Meter Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Blood Ketone Meter Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Blood Ketone Meter Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Blood Ketone Meter Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Blood Ketone Meter Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Blood Ketone Meter Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. South America Blood Ketone Meter Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Blood Ketone Meter Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Blood Ketone Meter Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Blood Ketone Meter Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Blood Ketone Meter Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. APEX Biotechnology Corporation
  • 15.3. TaiDoc Technology Corporation
  • 15.4. EKF Diagnostics Holdings plc
  • 15.5. Nipro Corporation
  • 15.6. ForaCare Inc.
  • 15.7. Menarini Diagnostics Srl
  • 15.8. ACON Laboratories Inc.
  • 15.9. GlucoRx Limited
  • 15.10. Illumina, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer